Teva spotlighted its schizophrenia portfolio at Psych Congress 2025, unveiling long-term Phase 3 data for its investigational once-monthly olanzapine...

Iovance Biotherapeutics has granted inducement stock options covering 22,810 shares to two new non-executive hires, with an exercise price...

Avicanna Latam SAS, a subsidiary of Avicanna Inc., has launched the re+play CBD wellness brand across the United States...

Decarbontek has launched a modular, fiber-based adsorbent platform intended to scale point-source carbon capture and direct air capture by...

Roche has secured a European CE mark for its port delivery platform with ranibizumab, to be marketed as Contivue...

Novo Nordisk will bring 35 presentations to EASD 2025 in Vienna, spanning late- and early-stage evidence across its semaglutide...

Idorsia has launched IMPACT-HTN with the Stanford Hypertension Center and Duke Heart Center, a three-phase initiative designed to standardize...

Marine Biologics has struck an exclusive partnership with Molecular Quantum Solutions that makes it the sole commercialization channel for...

Nanobiotix reported new Phase 1 data in primary cutaneous melanoma showing that a one-time intratumoral injection of JNJ-1900 (NBTXR3),...

Rezolute reported fiscal 2025 results alongside two pivotal clinical inflection points for its lead asset, ersodetug: completion of enrollment...